TFOS DEWS II: a year on…

It’s been a full year since the outcomes of the Tear Film & Ocular Surface Society’s second Dry Eye Workshop (now better known as TFOS DEWS II) were released to the world in a series of 10 reports that distilled the scientific evidence and provided an updated global consensus view on various aspects of dry eye… and what a year it’s been!

Whether it was greater public awareness; increased recognition of the impact dry eye has on quality of life; a sense of optimism that there are more available therapeutic options than ever to make a difference to affected patients’ lives; or simply a lack of patience to see the long-promised outcomes of the two and a half years’ of effort by more than 150 experts, I’m not sure, but the results were certainly eagerly awaited by researchers, clinicians, industry, regulators and patients alike.

Allergic to glasses?

Ugly, red blotches; itchy, inflamed spots; oozing sores. No, this is not a description of a zombie from the latest horror flick, but a patient suffering...

Diabetes, dry eye and ‘Substance P’?

Diabetes has now reached epidemic proportions affecting millions of people across the world. It is estimated around 54% of patients with diabetes suffer...

Dry eye and autologous serum?

The tear film and ocular surface are extremely complex, with tear film playing a vital role in maintaining ocular surface health. Not only does it provide...

Summer’s blight: pterygia

A pterygium is a common benign ocular surface growth. It typically starts on the nasal conjunctiva close to the limbus as a pinkish, triangular tissue...

Understanding the “lid wiper”

We blink around 10,000 times a day, with the eyelids traversing the length of a football pitch in distance each day. Wiping over the eye’s surface with...

Bottom Banner Advert